COVID-19 Records

Tony's Diary Package — page 1026

of 1141 pages

← p.1025 p.1027 → · this page in the original PDF · package

Was a yn Network to test COVID vaccines and treatments. JatientMay 24: NIH created a public COVID-19 OpenData Portal to openly and quickly share COVID-19-related drug repurposing data and COVID-19 variant-specific effects against all approved drugs. It was a key resource for the ACTIV Tracking Resistance And Coronavirus Evolution (TRACE) efforts. Blurb: COVID-19 OpenData Portal shares data on drug repurposing and variant effects with drugs. Image: 5.20 COVID Data Portal variants July 8: NIH launched the COVID-19 Prevention Network (COVPN), a clinical trials network to test COVID-19 vaccines and other prevention tools. Press release Blurb: NIH launched COVID-19 Prevention Network to test COVID vaccines and treatments. July 27: The Phase 3 clinical trial started for the investigational vaccine mRNA-1273, co-developed by NIH and Moderna. The trial enrolled approximately 30,000 adult volunteers who did not have COVID-19. Press release Blurb: NIH/Moderna COVID vaccine Phase 3 clinical trial began, enrolling ≈30,000 adult volunteers. Image: https://www.shutterstock.com/image-photo/covid19-vaccination-asian-male-patientgetting-1831245058 August 4: NIH launches the first ACTIV clinical trials to test the safety and efficacy of treatments both for mild and moderate COVID-19 patients and for patients hospitalized with COVID-19. ACTIV-2 press release, ACTIV-3 Press Release Blurb: First ACTIV trials to evaluate the safety and efficacy of COVID therapeutics begin. Image: 8.4.20 ACTIV trials September 16: Recognizing the need to ensure inclusive participation in vaccine trials, NIH launched Community Engagement Alliance (CEAL) Against COVID-19 Disparities. CEAL provided outreach and engagement opportunities in racial and ethnic minority communities disproportionately affected by the COVID-19 pandemic. (In 2021, NIH supplemented the effort with $29 million in funding from the American Rescue Plan). September press release Blurb: NIH launched CEAL to ensure diversity in vaccine trials and reach out to disproportionately affected communities. Image: 9.16.20 CEAL

This is our OCR of the page, with running headers and footers removed. The Committee's PDF is authoritative; quote from it. Machine-readable, including the uncleaned text: /api/page/fauci_diary/1026

Records on this page

RecordDateTypePages
August 16, 2022 2022-08-16 diary entry 1023–1031